Cardiology

EMPHASIS HF: Study shows epleronone to reduce atrial fibrillation

The aldosterone antagonist eplerenone (Inspra, Pfizer) significantly reduced the development of new onset atrial fibrillation and flutter (AFF) in patients with class 2 heart failure, concludes a sub-analysis of the EMPHASIS-HF ...

page 10 from 10